COVID-19

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

Walgreens has announced its commitment to getting ahead of an early and condensed flu season amid the COVID-19 pandemic.

Here's the coronavirus-related news from this week that you should know.

A Kawasaki-like inflammatory disease has affected children who have coronavirus disease 2019.

The pharmaceutical company increased production by more than 25% in the United States.

The Chinese Gastroenterology Expert Group and the Chinese Society of Gastroenterology published new management consensus for digestive disorders in patients with the coronavirus disease 2019.

The US government and Moderna are collaborating to produce 100 million doses of investigational COVID-19 vaccine candidate mRNA-1273.

Keep up-to-date on flu vaccine options and counseling considerations, especially as coronavirus disease 2019 continues to strike.

Experts worry that the approval is prioritizing the economy and national prestige over safety.

The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.

Here's this week's coronavirus-related news you should know.

Long-term care facilities will be the focus of Eli Lilly’s BLAZE-2 study for testing its LY-CoV555 antibody against SARS-CoV-2.

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.

Three scientists discuss the global race for a COVID-19 vaccine.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

Here's this week's coronavirus-related news.

NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.

In an open letter, the American Pharmacist Association’s (APhA) Board of Trustees called for Americans to continue following public health guidelines.

Unemployment rates compounded with high medical costs plague the diabetes community during the coronavirus disease 2019 (COVID-19) pandemic.

Several pharmacy organizations have stressed that the next coronavirus economic relief package should include provisions directed toward pharmacies.

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.

The American Pharmacists Association (APhA) urged Congress to take immediate action to expand coronavirus disease 2019 (COVID-19) testing services by granting pharmacists temporary provider status.

Here's this week's roundup of the coronavirus-related news you should know.

An inside look at the process from prescription to dispensing.

In a letter to President Trump, NCPA CEO explained that failure to implement sweeping DIR fee reform would be detrimental to independent community pharmacies and their patients.

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

The US government agreed to pay $1.95 billion for the first 100 million doses of Pfizer and BioNTech’s investigational candidate.